
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
TOP2A
Introduction
DNA topoisomerase 2-alpha is an enzyme that in humans is encoded by the TOP2A gene.
This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, alpha, is localized to chromosome 17 and the beta gene is localized to chromosome 3. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia.[1]
Interactions
Interactions
TOP2A has been shown to interact with HDAC1,[2][3] CDC5L,[4] Small ubiquitin-related modifier 1[5] and P53.[6]
References
References
- β “Entrez Gene: TOP2A topoisomerase (DNA) II alpha 170kDa”.
- β Tsai, S C; Valkov N; Yang W M; Gump J; Sullivan D; Seto E (November 2000). “Histone deacetylase interacts directly with DNA topoisomerase II”. Nat. Genet. UNITED STATES. 26 (3): 349β53. doi:10.1038/81671. ISSNΒ 1061-4036. PMIDΒ 11062478.
- β Johnson, C A; Padget K; Austin C A; Turner B M (February 2001). “Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis”. J. Biol. Chem. United States. 276 (7): 4539β42. doi:10.1074/jbc.C000824200. ISSNΒ 0021-9258. PMIDΒ 11136718.
- β Ajuh, P; Kuster B; Panov K; Zomerdijk J C; Mann M; Lamond A I (Dec 2000). “Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry”. EMBO J. ENGLAND. 19 (23): 6569β81. doi:10.1093/emboj/19.23.6569. ISSNΒ 0261-4189. PMCΒ 305846. PMIDΒ 11101529.
- β Mao, Y; Desai S D; Liu L F (August 2000). “SUMO-1 conjugation to human DNA topoisomerase II isozymes”. J. Biol. Chem. UNITED STATES. 275 (34): 26066β73. doi:10.1074/jbc.M001831200. ISSNΒ 0021-9258. PMIDΒ 10862613.
- β Cowell, I G; Okorokov A L; Cutts S A; Padget K; Bell M; Milner J; Austin C A (February 2000). “Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53”. Exp. Cell Res. UNITED STATES. 255 (1): 86β94. doi:10.1006/excr.1999.4772. ISSNΒ 0014-4827. PMIDΒ 10666337.
Further reading
Further reading
- Watt PM, Hickson ID (1994). “Structure and function of type II DNA topoisomerases”. Biochem. J. 303 (3): 681β95. PMCΒ 1137600. PMIDΒ 7980433.
- Bronner C, Hopfner R, Mousli M (2002). “Transcriptional regulation of the human topoisomerase IIalpha gene”. Anticancer Res. 22 (2A): 605β12. PMIDΒ 12014628.
- JΓ€rvinen TA, Liu ET (2004). “Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer–more common than anticipated”. Cytopathology. 14 (6): 309β13. doi:10.1046/j.0956-5507.2003.00105.x. PMIDΒ 14632727.
